Tirzepatide showed a noninferior reduction in all-cause mortality (HR 0.88, 95% CI 0.68 to 1.16), myocardial infarction (HR 0.91, 95% CI 0.73 to 1.12) and stroke (HR 0.78, 95% CI 0.59 to 1.03) compared to dulaglutide, although CIs remained compatible with no difference
The table below summarises the average weight loss reported in the main Phase 3 clinical trials for each treatment
Semaglutide impacts hormones that help regulate digestion, which can sometimes lead to loose or more frequent stools
Green Tea Extract A catechin, called epigallocatechin gallate (EGCG), when combined with caffeine, was shown to elevate metabolism beyond that of caffeine alone
Age 18-75 b
Although there may be some differences in drug absorption speed and peak time, from the perspective of long-term treatment effect, both can effectively improve the metabolic indicators of diabetes patients, and help obese patients lose weight and reduce the risk of related complications